HomePHARM • AMS
add
Pharming Group NV
Previous close
€0.83
Day range
€0.83 - €0.87
Year range
€0.65 - €0.97
Market cap
566.38M EUR
Avg Volume
9.19M
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 79.09M | 42.29% |
Operating expense | 70.02M | 10.24% |
Net income | -14.72M | -18.24% |
Net profit margin | -18.61 | 16.88% |
Earnings per share | -0.02 | -15.79% |
EBITDA | 3.34M | 132.12% |
Effective tax rate | -26.30% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 107.27M | -46.89% |
Total assets | 403.18M | -8.71% |
Total liabilities | 187.89M | -20.29% |
Total equity | 215.29M | — |
Shares outstanding | 669.05M | — |
Price to book | 2.60 | — |
Return on assets | 0.47% | — |
Return on capital | 0.57% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -14.72M | -18.24% |
Cash from operations | 232.00K | 103.03% |
Cash from investing | 9.69M | 1,359.49% |
Cash from financing | -6.72M | -171.91% |
Net change in cash | 5.15M | 152.28% |
Free cash flow | 2.58B | 180,862.58% |
About
Founded
1988
Website
Employees
404